What They List
- Psilocybin Research
- Clinical Trials
- Major Depression Study
Research
Usona Institute
Clinical Trial in Madison, Wisconsin
Usona Institute is developing psilocybin as a potential treatment for major depressive disorder. Its official psilocybin page describes the uAspire Phase 3 study, and ClinicalTrials.gov lists NCT06308653 with Usona Institute as lead sponsor.
ResearchClinical Trial
Directory Facts
- Status
- Research Institution
- Price
- Not published
- Hours
- Verify with provider
- License / Record
- Not listed
- Last Verified
- 2026-06-12
Location
Madison, WI
Source Notes
NCT06308653 is active-not-recruiting as of ClinicalTrials.gov check.
Source: https://www.usonainstitute.org/psilocybin; https://clinicaltrials.gov/study/NCT06308653
MagicMushroomsDirectory does not provide medical, legal, or purchasing advice. Verify current laws, provider status, and eligibility before contacting any listing.